George Washington University Research Professor Toshimitsu Hamasaki has recently earned a new publication distinction from the Journal of the American College of Cardiology. Dr. Hamasaki is a Research Professor with the Milken Institute School of Public Health’s GWU Biostatistics Center and the Department of Biostatistics and Bioinformatics whose research focuses on biopharmaceutical statistics and clinical trials. He is the author of over 200 peer-reviewed publications.
Dr. Hamasaki is the co-author of a 2019 paper from the Journal of the American College of Cardiology entitled “Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.” Hamasaki’s publication has recently been selected as one of the JACC Editor-in Chief’s Top Papers of 2019. Hamasaki was the lead statistician in the paper which reported results from the first prospective multicenter trial to evaluate the safety and efficacy of protocol-defined transplacental treatment in fetal with supraventricular tachycardia (SVT) and atrial flutter. For more information, see Publication Co-authored by Toshimitsu Hamasaki Selected as JACC Editor-in-Chief’s Selected the Top 100 Papers in 2019.
